Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Elicio Therapeutics Inc (ELTX)

Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Elicio Therapeutics Inc 451 D Street 5th Floor Boston MA 02210 USA

www.elicio.com Employees: 32 P: 857-209-0050

Sector:

Medical

Description:

Elicio Therapeutics is a privately-held clinical-stage biotechnology company. It involved in developing a pipeline of novel immunotherapies for the treatment of cancer and other diseases. Elicio Therapeutics, formerly known as Angion Biomedica Corp, is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 141,844
Enterprise Value, $K 123,044
Shares Outstanding, K 17,490
Float, K 8,588
% Float 49.10%
Short Interest, K 1,159
Short Float 6.63%
Days to Cover 14.23
Short Volume Ratio 0.69
% of Insider Shareholders 50.90%
% of Institutional Shareholders 35.03%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -51,900 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -10,080 K
EBIT, $ -42,360 K
EBITDA, $ -41,110 K

Growth:

1-Year Return -14.75%
3-Year Return 19.02%
5-Year Return -95.85%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.60 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -3.15
EPS Growth vs. Prev Qtr 9.09%
EPS Growth vs. Prev Year 56.83%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 06/02/23

ELTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -5,657.86%
Return-on-Assets % -160.71%
Profit Margin % 0.00%
Debt/Equity 2.54
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 34.68
Book Value/Share 0.23
Interest Coverage -111.83
60-Month Beta 1.19
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar